Association of the Monocyte to HDL-cholesterol Ratio with Idiopathic Pulmonary Arterial Hypertension and Disease Severity
PDF
Cite
Share
Request
Original Research
VOLUME: 3 ISSUE: 2
P: 189 - 196
2022

Association of the Monocyte to HDL-cholesterol Ratio with Idiopathic Pulmonary Arterial Hypertension and Disease Severity

Forbes J Med 2022;3(2):189-196
1. University of Health Sciences Turkey, İzmir Tepecik Training and Research Hospital, Clinic of Cardiology, İzmir, Turkey
2. Fırat University Faculty of Medicine, Department of Cardiology, Elazığ, Turkey
No information available.
No information available
Received Date: 2022-04-19T15:45:58
Accepted Date: 2022-08-04T14:21:52
PDF
Cite
Share
Request

Abstract

Objective: Idiopathic pulmonary arterial hypertension (IPAH) is a disease characterized by abnormal vascular changes in the pulmonary arteries, leading to elevated pulmonary artery pressure. In this retrospective study, we investigated the role of monocyte to high-density lipoprotein-cholesterol ratio in predicting IPAH and disease severity.

Methods: Thirty-three patients with IPAH were compared with the 25 healthy controls according to their demographic characteristics, laboratory and echocardiographic parameters. Baseline and year 1 data of patients with pulmonary hypertension who received drug-therapy were also compared. The predictive value of the monocyte to high-density lipoprotein-cholesterol ratio for IPAH and its change with disease severity were examined.

Results: The monocyte to high-density lipoprotein-cholesterol ratio was significantly higher in patients with IPAH (p=0.009). In receiver operating characteristic curve analysis, monocyte to high-density lipoprotein-cholesterol ratio >11.05% predicted idiopathic pulmonary hypertension. In drug-treated patients, monocyte to high-density lipoprotein-cholesterol ratio in year 1 was significantly lower than the baseline (p<0.001). Among the patients with pulmonary hypertension, the group in which risk stratification improved from high risk to low showed the greatest reduction in monocyte to high-density lipoprotein-cholesterol ratio. A significant positive correlation was found between the percentage reduction in monocyte to high-density lipoprotein-cholesterol ratio and the percentage reduction in pulmonary vascular resistance from baseline to year 1 (p=0.003).

Conclusion: Monocyte to high-density lipoprotein-cholesterol ratio may be a promising parameter in the assessment and management of patients with IPAH.

Keywords:
HDL-C, monocyte, pulmonary hypertension